Palivizumab prophylaxis for respiratory syncytial virus (RSV) in infants with cystic fibrosis (CF) and respiratory illness hospitalizations

Candice Bjornson (Calgary, Canada), Candice Bjornson, Parco Chan, Abby Li, Bosco Paes, Krista Lanctot, Ian Mitchell

Source: International Congress 2015 – Paediatric pulmonary infections
Session: Paediatric pulmonary infections
Session type: Poster Discussion
Number: 3625
Disease area: Paediatric lung diseases, Respiratory infections

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Candice Bjornson (Calgary, Canada), Candice Bjornson, Parco Chan, Abby Li, Bosco Paes, Krista Lanctot, Ian Mitchell. Palivizumab prophylaxis for respiratory syncytial virus (RSV) in infants with cystic fibrosis (CF) and respiratory illness hospitalizations. Eur Respir J 2015; 46: Suppl. 59, 3625

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Respiratory viral agents in cystic fibrosis
Source: Annual Congress 2005 - Cystic fibrosis lung disease: pieces of the puzzle
Year: 2005


Relationship between respiratory syncytial virus bronchiolitis and future obstructive airway diseases
Source: Eur Respir J 2001; 18: 1044-1058
Year: 2001



DNase treatment for atelectasis in infants with severe respiratory syncytial virus bronchiolitis
Source: Eur Respir J 2001; 18: 734-737
Year: 2001



Prevalence of respiratory syncytial virus (RSV) hospitalisation, and subsequent airway symptoms in late preterm infants
Source: Annual Congress 2008 - Paediatric respiratory epidemiology II: air pollution studies and infectious disease epidemiology
Year: 2008

Are infants with respiratory syncytial virus (RSV) bronchiolitis different from infants with non RSV bronchiolitis for the development of wheezing in the first year of life?
Source: Eur Respir J 2005; 26: Suppl. 49, 27s
Year: 2005

Lung function impairment in term infants developing respiratory syncytial virus bronchiolitis is pre-existent in previously healthy infants
Source: Annual Congress 2013 –Paediatric respiratory epidemiology: bronchiolitis and asthma
Year: 2013

Prospective study on the contribution of respiratory syncytial virus (RSV) to acute lower respiratory tract infections (ALRTI) in young hospitalised children
Source: Eur Respir J 2004; 24: Suppl. 48, 622s
Year: 2004

Bronchiolitis in infants and children
Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-50-2, page=170
Year: 2006

Interleukin-9 in severe respiratory syncytial virus (RSV) bronchiolitis
Source: Eur Respir J 2002; 20: Suppl. 38, 17s
Year: 2002

Respiratory viruses in adults with cystic fibrosis during stable and exacerbations
Source: International Congress 2019 – Complex respiratory infections in clinical practice
Year: 2019

Respiratory infections in paediatrics: from pneumonia to cystic fibrosis
Source: Annual Congress 2007 - Infections year in review
Year: 2007


Respiratory infections in children: from respiratory syncytial virus to tuberculosis
Source: International Congress 2019 – Paediatric Year in review
Year: 2019


Prevalence of respiratory syncytial virus infection among Philippino children with bronchiolitis
Source: Eur Respir J 2002; 20: Suppl. 38, 17s
Year: 2002

Respiratory syncytial virus infection in childcare and hospitalized children with different respiratory disease severity
Source: Annual Congress 2006 - Virus-induced respiratory tract infection
Year: 2006


High risk of nosocomial-acquired respiratory syncytial virus (RSV) infection in children with congenital heart disease (CHD)
Source: Eur Respir J 2004; 24: Suppl. 48, 392s
Year: 2004

Viral infections trigger exacerbations of cystic fibrosis in adults and children
Source: Eur Respir J 2012; 40: 510-512
Year: 2012


Cromoglycate in the treatment of respiratory syncytial virus (RSV) bronchiolitis
Source: Eur Respir J 2001; 18: Suppl. 33, 169s
Year: 2001

Respiratory syncytial virus (RSV) hospitalization in infants with congenital airway anomalies (CAA) in the canadian registry of palivizumab (CARESS) after prophylaxis (2005-2012)
Source: International Congress 2014 – Paediatric epidemiology: new insights into primary ciliary dyskinesia, prematurity and bronchiolitis
Year: 2014

Decreased lung function precedes severe respiratory syncytial virus infection and post-respiratory syncytial virus wheeze in term infants
Source: Eur Respir J 2014; 44: 666-674
Year: 2014



Increasing severity of bronchiolitis in children with respiratory syncytial virus A ON1
Source: International Congress 2019 – New insights into childhood infections: from viral bronchiolitis to bronchiolitis obliterans
Year: 2019